European Case Law Identifier: | ECLI:EP:BA:1998:T049894.19980622 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 22 June 1998 | ||||||||
Case number: | T 0498/94 | ||||||||
Application number: | 81300047.8 | ||||||||
IPC class: | C12P 1/00 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Hybrid cell line for producing monoclonal antibody to a human T cell antigen, antibody, and methods | ||||||||
Applicant name: | Ortho Pharmaceutical Corporation | ||||||||
Opponent name: | Behringwerke Aktiengesellschaft Novartis Patent- und Markenabteilung Boehringer Mannheim GmbH Patentabteilung Becton, Dickinson and Company F. Hoffmann-La Roche & Co. Aktiengesellschaft |
||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Sufficiency of disclosure - (no) Inventive step (no) |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t940498eu1.html
Date retrieved: 17 May 2021